Yıl: 2020 Cilt: 30 Sayı: 1 Sayfa Aralığı: 39 - 43 Metin Dili: İngilizce DOI: 10.5222/terh.2020.50570 İndeks Tarihi: 20-11-2020

Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease

Öz:
Objective: In recent years neutrophil-to-lymphocyte ratio is defined as one of the new and early prognostic markersfor many carcinomas including some types of intracranial tumors. The aim of the present study is to assess theassociation between preoperative and postoperative neutrophil-to-lymphocyte ratios and remissions in patientswith Cushing’s disease.Method: The present study was carried out using the data of 162 consecutive patients operated for Cushing’sdisease by a single surgeon (NG) between 1997 and 2017. Clinical records were analyzed retrospectively.Neutrophil-to-lymphocyte ratios calculated from complete blood counts recorded preoperatively, on postoperative1st day and at postoperative 3rd month in 24 patients in early, and 3rd month remissions and correlations amongthem were investigated.Results: A statistically significant difference was observed between preoperative, postoperative 1st day and postoperative 3rd month NLRs in patients who were in early stage emission (p=0.001) or not (p=0.002). Any statisticallysignificant difference was not found between patients who were in remission or not at 3rd months in terms of NLRsmeasured at different time points. There was a statistically significant difference between preoperative, postoperative first day and postoperative 3rd month NLRs in patients in remission (p=0.001) or not (p=0.005) during longterm follow-up. No statistically significant difference was found between NLRs measured at different times amongthose who were remission or not during long-term follow-up.Conclusion: Cushing’s disease is a disease directly associated with stress hormones and its effects on NLR is inevitable. New studies with larger patient series will shed light on this issue.
Anahtar Kelime:

Cushing Hastalığı Remisyon Değerlendirmesinde Nötrofil Lenfosit Oranının Yeri

Öz:
Amaç: Son yıllarda nötrofil lenfosit oranı bazı beyin tümörü tiplerini de içeren pek çok kanser için erken prognostik faktörlerden biri olarak tanımlanmıştır. Çalışmanın amacı Cushing hastalarında operasyon öncesi ve sonrası nötrofil lenfosit oranları ile remisyon arası ilişkiyi araştırmaktır. Yöntem: Çalışma Cushing hastalığı tanısıyla 1997 ila 2017 yılları arasında tek bir cerrah (NG) tarafından opere edilmiş ardışık 162 hastanın bilgileri retrospektif olarak araştırılarak gerçekleştirilmiştir. Çalışma kriterlerini karşılayan 24 hastanın operasyon öncesi, postoperatif 1. gün ve postoperatif 3. ay tam kan sayımı değerlerinden hesaplanan nötrofil lenfosit oranları ile erken remisyon ve 3. ay remisyona girmiş olma durumları karşılaştırılarak arasındaki ilişki araştırıldı. Bulgular: Preoperatif, postoperatif 1.gün ve postoperatif 3. ay nötrofil lenfosit oranının erken remisyona giren hasta grubunda (p=0,001) ve erken remisyona girmeyen grup hastalarda da (p=0,002) anlamlı farklı olduğu gözlendi. Ancak 3. ay remisyona giren grupta ve remisyona girmeyen grupta ölçülen nötrofil lenfosit oranları arası fark anlamlı bulunmadı. Uzun dönem takipte olup remisyonda olan ve remisyona girmemiş olguların operasyon öncesi, postoperatif 1. gün ve postoperatif 3. ayda bakılan nötrofil lenfosit oranları arasında anlamlı bir fark bulundu. Ancak uzun dönem takiplerinde remisyonda olan hastalar (p=0,001) ile remisyona girmemiş hastaların (p=0,005) oranları arasında anlamlı bir fark bulunmamıştır. Sonuç: Cushing hastalığı stres hormonları ile direkt bağlantılı bir hastalıktır ve bunun nötrofil lenfosit oranlarına etkisi kaçınılmazdır. Daha geniş serilerle yapılacak çalışmalar bu konuya ışık tutacaktır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101:613-9. [CrossRef]
  • 2. Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing’s syndrome: state of the art. THE LANCET Diabetes & Endocrinology. 2016;4:611- 29. [CrossRef]
  • 3. Qiao N, Swearingen B, Tritos NA. Cushing’s disease in older patients: Presentation and outcome. Clin Endocrinol (Oxf). 2018;89:444-53. [CrossRef]
  • 4. Meng LB, Yu ZM, Guo P, et al. Neutrophils and neutrophillymphocyte ratio: Inflammatory markers associated with intimal-media thickness of atherosclerosis. Thromb Res. 2018;170:45-52. [CrossRef]
  • 5. Getzler I, Bahouth Z, Nativ O, Rubinstein J, Halachmi S. Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer. BMC Urol. 2018;18:90. [CrossRef]
  • 6. Greenhill C. Pituitary disease: Inflammation in patients with Cushing disease. Nat Rev Endocrinol. 2016;12:687. [CrossRef]
  • 7. Zadora P, Dabrowski W, Czarko K, et al. Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - a pilot study. Neurol Neurochir Pol. 2015;49:41-4. [CrossRef]
  • 8. Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 2011;21:264-75. [CrossRef]
  • 9. Cedrés S, Torrejon D, Martínez A, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol. 2012;14:864-9. [CrossRef]
  • 10. Cananzi FCM, Minerva EM, Samà L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119:12-20. [CrossRef]
  • 11. Mao R, Zhao JJ, Bi XY, et al. A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver Metastases. J Gastrointest Surg;23:563-70. [CrossRef]
  • 12. Altman LC, Hill JS, Hairfield WM, Mullarkey MF. Effects of corticosteroids on eosinophil chemotaxis and adherence. J Clin Invest.1981;67:28-36. [CrossRef]
  • 13. Karakonstantis S, Kalemaki D, Tzagkarakis E, Lydakis C. Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio. Infect Dis (Lond). 2018;50:163-74. [CrossRef]
  • 14. Hills AG, Forsham PH, Finch CA. Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone in man. Blood. 1948;3:755-68. [CrossRef]
APA Camlar M, BİLGİN B, Ören M, KINALI B, ERDEN MELİKOGLU S, Gazioglu N (2020). Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. , 39 - 43. 10.5222/terh.2020.50570
Chicago Camlar Mahmut,BİLGİN Berra,Ören Merve,KINALI BURAK,ERDEN MELİKOGLU SECİL,Gazioglu Nurperi Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. (2020): 39 - 43. 10.5222/terh.2020.50570
MLA Camlar Mahmut,BİLGİN Berra,Ören Merve,KINALI BURAK,ERDEN MELİKOGLU SECİL,Gazioglu Nurperi Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. , 2020, ss.39 - 43. 10.5222/terh.2020.50570
AMA Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. . 2020; 39 - 43. 10.5222/terh.2020.50570
Vancouver Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. . 2020; 39 - 43. 10.5222/terh.2020.50570
IEEE Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N "Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease." , ss.39 - 43, 2020. 10.5222/terh.2020.50570
ISNAD Camlar, Mahmut vd. "Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease". (2020), 39-43. https://doi.org/10.5222/terh.2020.50570
APA Camlar M, BİLGİN B, Ören M, KINALI B, ERDEN MELİKOGLU S, Gazioglu N (2020). Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. İzmir Tepecik Eğitim Hastanesi Dergisi, 30(1), 39 - 43. 10.5222/terh.2020.50570
Chicago Camlar Mahmut,BİLGİN Berra,Ören Merve,KINALI BURAK,ERDEN MELİKOGLU SECİL,Gazioglu Nurperi Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. İzmir Tepecik Eğitim Hastanesi Dergisi 30, no.1 (2020): 39 - 43. 10.5222/terh.2020.50570
MLA Camlar Mahmut,BİLGİN Berra,Ören Merve,KINALI BURAK,ERDEN MELİKOGLU SECİL,Gazioglu Nurperi Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. İzmir Tepecik Eğitim Hastanesi Dergisi, vol.30, no.1, 2020, ss.39 - 43. 10.5222/terh.2020.50570
AMA Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. İzmir Tepecik Eğitim Hastanesi Dergisi. 2020; 30(1): 39 - 43. 10.5222/terh.2020.50570
Vancouver Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease. İzmir Tepecik Eğitim Hastanesi Dergisi. 2020; 30(1): 39 - 43. 10.5222/terh.2020.50570
IEEE Camlar M,BİLGİN B,Ören M,KINALI B,ERDEN MELİKOGLU S,Gazioglu N "Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease." İzmir Tepecik Eğitim Hastanesi Dergisi, 30, ss.39 - 43, 2020. 10.5222/terh.2020.50570
ISNAD Camlar, Mahmut vd. "Predictive Value of Neutrophil-to-Lymphocyte Ratio for the Assessment of Remission in Cushing’s Disease". İzmir Tepecik Eğitim Hastanesi Dergisi 30/1 (2020), 39-43. https://doi.org/10.5222/terh.2020.50570